Distinct regions of EBV DNase are required for nuclease and DNA binding activities.

Epstein-Barr virus (EBV) DNase possesses both endonuclease and exonuclease activities and accepts both double-stranded DNA (dsDNA) and single-stranded DNA (ssDNA) as substrates. To map regions of EBV DNase responsible for nuclease and DNA binding activities, a series of mutant DNase polypeptides was expressed using a bacterial system for the nuclease assay and in an in vitro transcription/translation system to assay binding activity to dsDNA or ssDNA cellulose. The results indicated that the C-terminus of EBV DNase, residues 450-460, is essential for nuclease activity but dispensable for DNA binding. However, deletion of residues 441-470 resulted in the loss of both nuclease and DNA binding activities. Substitution of Phe452 and Val458 led to inactive enzymes. In the N-terminus, deletion of residues 23-28 and residues 7-61 resulted in the loss of nuclease activity but the DNA binding activities of the deleted enzymes were intermediate and low, respectively. Mutation of Leu23 to Gly showed drastically reduced nuclease activity but its DNA binding ability was not affected. Based on the amino acid sequence alignment of various herpesvirus DNases, we chose four highly conserved and two less well conserved regions as controls for mutagenesis studies. These six internal deletion (ID) mutants were prepared using a recombinant PCR method. Each of the polypeptides was expressed in a bacterial system for the nuclease assay and using an in vitro transcription/translation system for the DNA binding assay. DNA binding and nuclease activities of all six internal deletion mutants were abolished, except that mutant ID2, with deletion of residues 138-152, retained an intermediate ability to bind DNA. These data indicate that since mutations at distinct regions within EBV DNase resulted in the loss of nuclease and/or DNA binding activities, it is suggested that these distinct regions are required for maintenance of an intact and highly ordered structure(s) for both activities.

[1]  Ching‐Hwa Tsai,et al.  Characterization of Monoclonal Antibodies to the Zta and DNase Proteins of Epstein-Barr Virus. , 1997, Journal of biomedical science.

[2]  S. Weller,et al.  Herpes simplex virus type 1 alkaline nuclease is required for efficient processing of viral DNA replication intermediates , 1996, Journal of virology.

[3]  J. Chen,et al.  Characterization of Epstein-Barr virus DNase and its interaction with the major DNA binding protein. , 1995, Virology.

[4]  S. W. Lin,et al.  Functional analysis of the amino terminus of Epstein-Barr virus deoxyribonuclease. , 1994, Virology.

[5]  J. Chen,et al.  Use of bacterially-expressed antigen for detection of antibodies to the EBV-specific deoxyribonuclease in sera from patients with nasopharyngeal carcinoma. , 1993, Journal of virological methods.

[6]  M. Daibata,et al.  Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells. , 1993, Virology.

[7]  S. Weller,et al.  Herpes simplex virus 1 alkaline nuclease is required for efficient egress of capsids from the nucleus. , 1993, Virology.

[8]  J. Chen,et al.  Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. , 1991, Blood.

[9]  R. S. Tan,et al.  Chromatographic purification and characterization of EBV DNase from chemically induced lymphoid cells. , 1990, Virology.

[10]  Chien-Jen Chen,et al.  Antibody to Epstein‐Barr virus‐specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan , 1989, Journal of medical virology.

[11]  R. Warnke,et al.  Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. , 1989, The New England journal of medicine.

[12]  E. Lennette,et al.  Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. , 1985, The New England journal of medicine.

[13]  C. J. Chen,et al.  Antibody to Epstein‐Barr virus‐specific DNase as a marker for the early detection of nasopharyngeal carcinoma , 1985, Journal of medical virology.

[14]  L. Hwang,et al.  Antibody response to Epstein‐Barr‐virus‐specific DNase in 13 patients with nasopharyngeal carcinoma in Taiwan: A retrospective study , 1985, Journal of medical virology.

[15]  W. Kabsch,et al.  Three‐dimensional structure of bovine pancreatic DNase I at 2.5 A resolution. , 1984, The EMBO journal.

[16]  J. Chen,et al.  Antibody to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma. , 1982, Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology.

[17]  H. Ochs,et al.  Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry. , 1982, The American journal of medicine.

[18]  J. Chen,et al.  Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Clough An endonuclease isolated from Epstein-Barr virus-producing human lymphoblastoid cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Chen,et al.  Studies on the activity of DNase associated with the replication of the Epstein-Barr virus. , 1980, Virology.

[21]  W. Clough Deoxyribonuclease activity found in Epstein--Barr virus producing lymphoblastoid cells. , 1979, Biochemistry.

[22]  T. Liao Reversible inactivation of pancreatic deoxyribonuclease A by sodium dodecyl sulfate. Removal of COOH-terminal residues from the denatured protein by carboxypeptidase A. , 1975, The Journal of biological chemistry.

[23]  M. Lin The structural roles of amino acid residues near the carboxyl terminus of bovine pancreatic ribonuclease A. , 1970, The Journal of biological chemistry.

[24]  W. Henle,et al.  Differential Reactivity of Human Serums with Early Antigens Induced by Epstein-Barr Virus , 1970, Science.

[25]  V. Diehl,et al.  Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Epstein,et al.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.